Life Sciences startup ecosystem
We track 57 organisations in this sector across 6+ countries.
Showing 41–57 of 57Life Sciences
Countries in this sector
Sectors alongside this one
Life Sciences results
Sofia Tech Park
Sofia Tech Park is Bulgaria's first state-owned science and technology park, incorporated in 2012 and officially opened in December 2015. It provides a business incubator supporting 40+ startups, 11 high-tech laboratories across ICT, life sciences, and clean energy, and the John Atanasoff Innovation Forum. The park hosts over 300 events annually and attracted more than 9 million BGN in company investment in 2023. It serves as a knowledge-economy hub for Bulgaria and the wider Balkan region.
Sofinnova Partners
Sofinnova Partners is a life-sciences venture capital firm founded in 1972 and managing over EUR 4 billion. It invests from seed to later stage across biopharma, medtech, digital medicine, agriculture and industrial processes, running seven distinct investment strategies across the value chain.
Sound Bioventures
Sound Bioventures is a Nordic life science venture capital firm investing in early-stage biotechnology, pharmaceutical, and medical technology companies in Scandinavia and the Baltic region. The firm focuses on science-driven innovation in therapeutics and diagnostics and is an active sponsor of the Nordic life science community. It served as Investor Dinner Sponsor at Nordic Life Science Days 2026.
Stina Wallmark
Stina Wallmark is Investment Director for Life Sciences at Voima Ventures, a leading Finnish venture capital firm investing in deep technology and life sciences startups. She focuses on early-stage science-based companies in the Nordic and Baltic region. Voima Ventures is recognized as one of Finland's most active investors in transformative science-based innovation across health, biology, and materials.
SwedenBIO
SwedenBIO is Sweden's national trade and interest organization for the life science industry, representing biotechnology, pharmaceutical, and medtech companies. Through its commercial arm SwedenBIO Service AB, it owns and produces Nordic Life Science Days (NLSDays), the largest Nordic partnering event for the life sciences sector. The organization advocates for Swedish life science competitiveness, innovation policy, and industry development at national and international levels.
Swiss Nordic Bio 2026
A high-level partnering and investor conference connecting life-science innovators, investors, and industry across Switzerland, Austria, and the Nordics. For a biotech or healthtech founder it provides structured 1-to-1 partnering meetings with investors and pharma in a focused single-day format.
TechBBQ 2026
The startup event of the Nordics: the 14th edition of TechBBQ moves to Bella Center Copenhagen on 26-27 August 2026, gathering 10,000+ founders, investors and builders from 50+ countries across two days. Programming spans AI, life sciences and deep tech, a startup pitch competition and AI-powered matchmaking. Backed by the Danish Industry Foundation, the Novo Nordisk Foundation and Realdania.
Technology Park Ljubljana
Technology Park Ljubljana (TP LJ) was established in 1995 and is one of the largest innovation ecosystems for the commercialisation of technology in South East Europe. It spans two locations with over 75,000 m² of workspace and hosts more than 300 companies and 1,500 employees, including notable Slovenian tech companies such as Cosylab and XLAB. The park provides incubation, mentoring, acceleration through its BALI programme, and networking for early-stage and growth-stage tech ventures. It is regarded as the foundational pillar of Slovenia's startup support infrastructure.
Uppsala Innovation Centre
Uppsala Innovation Centre (UIC) is a leading Swedish incubator and accelerator, consistently ranked among Europe’s top public incubators. Founded in 1999 and located in Uppsala – a city known for its major university and pharma industry cluster – UIC supports startups from idea to growth, with a strong focus on life sciences, medtech, energy, and IT. It is a public-private partnership, co-owned by Uppsala municipality, Uppsala University, SLU (Swedish University of Agricultural Sciences), and local industry. UIC offers a suite of programs: a pre-incubation phase for concept validation, a core incubation phase (up to 2 years) for business development and raising seed capital, and a accelerator phase for scaling up and internationalization. Uniquely, UIC doesn’t take equity but charges a modest fee – hence it’s seen as a neutral player with the startup’s interest at heart. Startups benefit from individualized coaching by experienced business advisors, free office and lab space, and connections to Uppsala’s rich network of experts (the city hosts big players like GE Healthcare, Pfizer, etc.). Access to lab facilities is a key advantage for biotech startups – UIC arranges subsidized lab rentals through partnerships with SLU and local science parks. Over 20+ years, UIC has nurtured over 1,000 companies. Alumni include OssDsign (innovative cranial implants, now publicly listed) and ScandiNova (pulsed power systems, a world leader in its niche). The incubator’s portfolio has also seen several acquisitions by international firms. UIC is particularly known for helping research-heavy projects with commercialization – many UIC startups are founded by professors or PhDs aiming to solve real-world problems with their inventions. They also run UIC “Business Lab” and “Startup Bootcamps” for very early-stage teams, including student entrepreneurs. UIC’s impact is evident: Uppsala punches above its weight in innovation metrics, and UIC has been recognized by UBI Global as a top-5 global incubator in 2019. By coupling Uppsala’s academic prowess with professional business guidance, Uppsala Innovation Centre continues to turn ideas “from lab to market,” driving regional growth and bringing science-based innovations to society.
Victor Decrion
Victor Decrion is Managing Partner at Lauxera Capital Partners, a European venture capital firm specializing in cardiovascular disease therapeutics and cardiometabolic drug development. He is a notable life science investor active in the European and Nordic biotech partnering ecosystem. Lauxera Capital is recognized for its focused thesis in cardiovascular innovation, an underserved area in European life science VC.
ViennaUP 2026
Decentralized city-wide startup festival across 50+ partner events over nine days with 10,000+ international attendees, 1,500+ startups, and active investor matchmaking. Most sessions free or low-cost; main-stage passes around EUR 200. Tracks span social impact, smart city, life sciences, and creative tech, a key CEE entry point for founders.
Vinnova
Vinnova is Sweden's innovation agency, responsible for fostering sustainable growth through research, development, and innovation. It distributes approximately SEK 3 billion annually in grants and co-funding to businesses, universities, research institutes, and public organizations across Sweden. Vinnova is a key government body enabling innovation in life sciences, digital health, and technology, and served as a Spotlight Panel Host at Nordic Life Science Days 2026.
Visiopharm
Visiopharm is a Hoersholm-based AI-driven precision pathology company, legally Visiopharm A/S, that builds image analysis software combining 20 years of pathology and research experience with AI. Its products span tissue image analysis for research (Discovery), spatial biology multiplexed image analysis (Phenoplex), and CE-IVD diagnostic apps used with digital pathology scanners and PACS-IMS integrations, serving pharma services, drug development, and diagnostics customers. The company holds Quality System Certification and is headquartered at Agern Alle 24, Hoersholm, Denmark.
Voima Ventures
Voima Ventures was founded in 2019 in Helsinki by Inka Mero, a serial entrepreneur and investor, and specialises exclusively in science-based deep tech spin-outs from universities and research institutions across the Nordics and Baltics. The firm raised its third fund of €90 million in 2023, bringing total assets above €100 million, and invests €200,000–€3 million at the earliest stages in biotech, quantum, AI, energy, climate, and life sciences. Over 70% of its 51 portfolio companies originate directly from academic labs, including Solar Foods. Voima is one of the few female-founded and female-led VC funds in the Nordics.
World Health Summit 2026 (October 2026)
The World Health Summit is one of the world's leading strategic forums for global health, held annually in Berlin under the patronage of the German government. The event convenes senior leaders from politics, science, the private sector and civil society. For founders it is a high-level networking and policy stage relevant to digital health, medtech and life sciences ventures.
World Health Summit Foundation
Foundation under Charité – Universitätsmedizin Berlin that organizes the annual World Health Summit, one of the world's leading strategic forums for global health. Held in Berlin under the patronage of the German government, it convenes leaders from politics, science, the private sector and civil society.
Zoë Johnson
Zoë Johnson heads Gubra Ventures as Head of Ventures at Gubra, a Danish bioscience company focused on metabolic diseases and CNS disorders. Gubra Ventures is the investment and partnering arm of Gubra, providing capital and expertise to early-stage biotech companies aligned with Gubra's scientific areas. She is an active investor and connector in the Nordic and European life science ecosystem.
